Kairos Pharma, Ltd. (KAPA) SEC filings

KAPA SEC filings moved a median of -2.83% by the close. KAPA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the KAPA overview →

65 measured KAPA SEC filing events.

Where these KAPA SEC filings landedvs 61 measured KAPA SEC filing reactions
KAPA SEC filingMiddle 50% · -7.58% to +1.24%Zero: 0.00%Median: -2.83%Median -2.83%-10.00%0+10.00%
Middle 50% of KAPA SEC filing reactions-7.58% to +1.24%
Median reaction (to close)-2.83%
Measured reactions61
Point-in-time · zero look-ahead

Half of the 61 KAPA SEC filing events with a measured close landed between -7.58% and +1.24%; 31% closed up.

DateHeadlineEvent5-minTo close
Form 8-K Kairos Pharma, LTD. For: Oct 06SEC filing · Form 8-K-1.89%-27.67%
Form 8-K Kairos Pharma, LTD. For: Sep 14SEC filing · Form 8-K+0.00%+3.35%
Form 8-K Kairos Pharma, LTD. For: Aug 21SEC filing · Form 8-K-12.69%-9.97%
Form 10-Q Kairos Pharma, LTD. For: Jun 30SEC filing · Form 10-Q-4.06%+1.52%
Form 8-K Kairos Pharma, LTD. For: Jul 16SEC filing · Form 8-K-13.13%-17.71%
Form 8-K Kairos Pharma, LTD. For: Jul 15SEC filing · Form 8-K-2.28%-7.10%
Form 8-K Kairos Pharma, LTD. For: Jun 29SEC filing · Form 8-K-0.03%-4.07%
Form 8-K Kairos Pharma, LTD. For: Jun 04SEC filing · Form 8-K-8.15%-5.32%
Form DEFA14A Kairos Pharma, LTD.SEC filing · Form DEFA14A—+1.69%
Form ARS Kairos Pharma, LTD. For: Dec 31SEC filing · Form ARS-3.57%-7.64%
Form DEF 14A Kairos Pharma, LTD. For: May 22SEC filing · Form DEF-3.57%-7.64%
Form 8-K Kairos Pharma, LTD. For: May 18SEC filing · Form 8-K+0.00%-2.83%
Form 10-Q Kairos Pharma, LTD. For: Mar 31SEC filing · Form 10-Q+1.91%+4.52%
Form PRE 14A Kairos Pharma, LTD. For: May 11SEC filing · Form PRE+0.00%+0.38%
Form 10-K Kairos Pharma, LTD. For: Dec 31SEC filing · Form 10-K+1.07%+4.84%
Form 8-K Kairos Pharma, LTD. For: Mar 02SEC filing · Form 8-K+2.05%+6.83%
Form 8-K Kairos Pharma, LTD. For: Feb 26SEC filing · Form 8-K-5.15%-23.98%
Form EFFECT Kairos Pharma, LTD.SEC filing · Form EFFECT-1.76%-6.93%
Form S-3 Kairos Pharma, LTD.SEC filing · Form S-3-4.44%-7.58%
Form 10-Q Kairos Pharma, LTD. For: Sep 30SEC filing · Form 10-Q+2.28%+3.34%
Form 8-K Kairos Pharma, LTD. For: Oct 08SEC filing · Form 8-K+0.85%+0.00%
Form 8-K Kairos Pharma, LTD. For: Oct 08SEC filing · Form 8-K+1.60%-6.40%
Form 8-K Kairos Pharma, LTD. For: Oct 01SEC filing · Form 8-K-5.26%-8.27%
Form 8-K Kairos Pharma, LTD. For: Sep 18SEC filing · Form 8-K-4.58%+2.29%
Form 8-K Kairos Pharma, LTD. For: Sep 11SEC filing · Form 8-K-1.89%-2.70%
Form 8-K Kairos Pharma, LTD. For: Sep 03SEC filing · Form 8-K-2.76%+0.69%
Form 10-Q Kairos Pharma, LTD. For: Jun 30SEC filing · Form 10-Q——
Form 10-K/A Kairos Pharma, LTD. For: Dec 31SEC filing · Form 10-K+0.90%+0.95%
Form 8-K Kairos Pharma, LTD. For: Jul 15SEC filing · Form 8-K-9.41%-31.18%
Form 8-K Kairos Pharma, LTD. For: Jun 10SEC filing · Form 8-K-2.83%-1.91%
Form 8-K Kairos Pharma, LTD. For: Jun 03SEC filing · Form 8-K-8.46%-14.66%
Form DEFR14A Kairos Pharma, LTD.SEC filing · Form DEFR14A-0.44%-0.28%
Form 10-Q Kairos Pharma, LTD. For: Mar 31SEC filing · Form 10-Q+0.00%+1.24%
Form PRER14A Kairos Pharma, LTD.SEC filing · Form PRER14A—+4.45%
Form DEF 14A Kairos Pharma, LTD. For: Apr 30SEC filing · Form DEF+0.00%-1.88%
Form 10-K/A Kairos Pharma, LTD. For: Dec 31SEC filing · Form 10-K-2.75%-6.20%
Form 8-K Kairos Pharma, LTD. For: Apr 23SEC filing · Form 8-K-2.75%-6.20%
Form EFFECT Kairos Pharma, LTD.SEC filing · Form EFFECT+0.00%+2.58%
Form 8-K Kairos Pharma, LTD. For: Apr 24SEC filing · Form 8-K-5.19%-1.95%
Form S-1 Kairos Pharma, LTD.SEC filing · Form S-1-4.25%-4.81%
Form 10-K Kairos Pharma, LTD. For: Dec 31SEC filing · Form 10-K-5.79%-12.75%
Form NT 10-K Kairos Pharma, LTD. For: Dec 31SEC filing · Form NT+0.00%-3.48%
Form 8-K Kairos Pharma, LTD. For: Mar 20SEC filing · Form 8-K+2.16%+6.31%
Form 8-K Kairos Pharma, LTD. For: Feb 26SEC filing · Form 8-K+0.00%+6.90%
Form DEF 14C Kairos Pharma, LTD. For: Feb 10SEC filing · Form DEF-1.05%-5.59%
Form 8-K Kairos Pharma, LTD. For: Feb 06SEC filing · Form 8-K-3.80%-8.86%
Form EFFECT Kairos Pharma, LTD.SEC filing · Form EFFECT-0.61%-3.66%
Form PRE 14C Kairos Pharma, LTD. For: Jan 29SEC filing · Form PRE+4.83%+3.45%
Form S-1 Kairos Pharma, LTD.SEC filing · Form S-1+4.83%+3.45%
Form D Kairos Pharma, LTD.SEC filing · Form D+4.83%+3.45%
Form 8-K Kairos Pharma, LTD. For: Jan 16SEC filing · Form 8-K-2.96%-12.64%
Form 8-K Kairos Pharma, LTD. For: Jan 14SEC filing · Form 8-K—-10.12%
Form 8-K Kairos Pharma, LTD. For: Dec 10SEC filing · Form 8-K+4.71%-2.06%
Form 8-K Kairos Pharma, LTD. For: Nov 19SEC filing · Form 8-K+3.63%-5.77%
Form 10-Q Kairos Pharma, LTD. For: Sep 30SEC filing · Form 10-Q-0.05%-3.95%
Form 8-K Kairos Pharma, LTD. For: Oct 09SEC filing · Form 8-K+0.00%-1.40%
Form 8-K Kairos Pharma, LTD. For: Oct 01SEC filing · Form 8-K+0.00%-2.27%
Form 8-K Kairos Pharma, LTD. For: Sep 23SEC filing · Form 8-K-2.50%-1.88%
Form S-8 Kairos Pharma, LTD.SEC filing · Form S-8-2.50%-1.88%
Form 8-K Kairos Pharma, LTD. For: Sep 20SEC filing · Form 8-K-17.62%-11.43%
Form 8-K Kairos Pharma, LTD. For: Sep 16SEC filing · Form 8-K+1.60%-8.00%
Form EFFECT Kairos Pharma, LTD.SEC filing · Form EFFECT+1.92%-5.38%
Form 8-A12B Kairos Pharma, LTD.SEC filing · Form 8-A12B——
Form CERT Kairos Pharma, LTD.SEC filing · Form CERT——
Form S-1/A Kairos Pharma, LTD.SEC filing · Form S-1——
That’s how KAPA usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More KAPA: earnings → · analyst actions → · KAPA overview →